Manager TitleAgeSince
Chief Executive Officer - 2017-11-21
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 337K
-2.69%-0.48%+51.67%+69.09% 66.33B
-0.92%+7.67%+14.26%+90.92% 60.62B
0.00%+0.39%+20.52%+98.45% 55.5B
+0.14%+2.35%+13.08%+109.47% 47.58B
-2.21%-2.47%+18.60%+36.89% 43.69B
-2.30%-10.40%+167.61%+776.79% 37.27B
+2.15%+1.42%+15.17%+56.49% 36.57B
-2.32%-2.24%+75.52%+52.70% 32.22B
+2.62%+5.90%-36.55%+406.95% 26.58B
Average -0.55%+0.05%+37.76%+188.64% 45B
Weighted average by Cap. -0.83%+0.20%+37.23%+162.19%
Logo TheraVet SA
TheraVet SA is specialized in the development of pharmaceutical products for the treatment of osteoarticular diseases in pets. At the end of 2023, the company had a portfolio of 2 products in the clinical development phase: Visco-Vet for the treatment of limping associated with osteoarthritis in dogs and Biocera-Vet for osseointegration and bone remodeling.
Employees
6
  1. Stock Market
  2. Stocks
  3. ALVET Stock